Washburn Capital Management’s PAVmed PAVM Stock Holding History

Washburn Capital Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-22	Closed	-$2.95K	–	49
2023 Q3	$2.95K	Hold	22	–	–	﹤0.01%	48
2023 Q2	$4.08K	Hold	22	–	–	﹤0.01%	45
2023 Q1	$3.73K	Hold	22	–	–	﹤0.01%	48
2022 Q4	$4.8K	Hold	22	–	–	﹤0.01%	47
2022 Q3	$9K	Buy	+22	New	+$12.5K	0.01%	49
2021 Q4	–	Sell	-37	Closed	-$141K	–	57
2021 Q3	$141K	Buy	37 +5	+16%	+$15.8K	0.09%	53
2021 Q2	$93K	Buy	+32	New	+$75.6K	0.06%	50
2020 Q4	–	Sell	-28	Closed	-$22K	–	55
2020 Q3	$22K	Hold	28	–	–	0.02%	51
2020 Q2	$26K	Buy	28 +6	+27%	+$6K	0.02%	50
2020 Q1	$20K	Buy	+22	New	+$18K	0.03%	40

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

Washburn Capital Management's PAVM Position: Q4 2023 in Review

Washburn Capital Management sold out of PAVmed (PAVM) in Q4 2023, closing a stake of 22 shares — an estimated $2.95K sold.

Washburn Capital Management first reported a position in PAVM in Q1 2020 and held it in 10 quarters. The position peaked at $141K in Q3 2021. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.

Washburn Capital Management reported no remaining PAVmed position as of Q4 2023 after selling out during the quarter.
Washburn Capital Management sold 22 PAVmed shares in Q4 2023, an estimated $2.95K.
Washburn Capital Management first reported a position in PAVmed in Q1 2020 and held it in 10 quarters.
Washburn Capital Management's PAVmed position peaked at $141K in Q3 2021.
23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.

Based on Washburn Capital Management's 13F filing for Q4 2023, filed 23 Jan 2024.